Korro Bio, Inc.
$9.27+1.31%(+$0.12)
TickerSpark Score
54/100
60
Valuation
40
Profitability
55
Growth
84
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KRRO research report →
52-Week Range8% of range
Low $5.20
Current $9.27
High $55.89
Companywww.korrobio.com
Korro Bio, Inc. , a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc.
- CEO
- Ram Aiyar
- IPO
- 2019
- Employees
- 112
- HQ
- Cambridge, MA, US
Price Chart
-42.17% · this period
Valuation
- Market Cap
- $92.27M
- P/E
- -0.95
- P/S
- 24.02
- P/B
- 0.90
- EV/EBITDA
- -0.94
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 73.22%
- Op Margin
- -2154.03%
- Net Margin
- -2954.14%
- ROE
- -117.86%
- ROIC
- -48.22%
Growth & Income
- Revenue
- $6.39M · 181.46%
- Net Income
- $-117,260,000 · -40.30%
- EPS
- $-12.48 · -33.19%
- Op Income
- $-87,342,000
- FCF YoY
- -1.41%
Performance & Tape
- 52W High
- $55.89
- 52W Low
- $5.20
- 50D MA
- $12.32
- 200D MA
- $18.49
- Beta
- 2.23
- Avg Volume
- 175.40K
Get TickerSpark's AI analysis on KRRO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Start Free Trial →Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 31, 26 | Lynx1 Capital Management LP | buy | 520 |
| Mar 31, 26 | Lynx1 Capital Management LP | other | 0 |
| Mar 10, 26 | Yang Rick | buy | 207,100 |
| Mar 10, 26 | Yang Rick | buy | 242,945 |
| Mar 10, 26 | SANDELL SCOTT D | buy | 207,100 |
| Mar 10, 26 | SANDELL SCOTT D | buy | 242,945 |
| Mar 10, 26 | New Enterprise Associates 17, L.P. | buy | 207,100 |
| Mar 10, 26 | New Enterprise Associates 17, L.P. | buy | 242,945 |
| Mar 10, 26 | Chang Carmen | buy | 207,100 |
| Mar 10, 26 | Chang Carmen | buy | 242,945 |
Our KRRO Coverage
We haven't published any research on KRRO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate KRRO Report →